Birchbrook, Inc. Crispr Therapeutics Ag Transaction History
Birchbrook, Inc.
- $187 Billion
- Q2 2025
A detailed history of Birchbrook, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Birchbrook, Inc. holds 1,050 shares of CRSP stock, worth $71,127. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,050
Previous 50
2000.0%
Holding current value
$71,127
Previous $1.7 Million
2900.71%
% of portfolio
0.03%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CRSP
# of Institutions
532Shares Held
68.7MCall Options Held
3.67MPut Options Held
2.25M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$690 Million4.09% of portfolio
-
Capital International Investors Los Angeles, CA5.59MShares$379 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.68MShares$249 Million0.11% of portfolio
-
State Street Corp Boston, MA3.27MShares$222 Million0.01% of portfolio
-
Ubs Group Ag2.84MShares$193 Million0.02% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $5.28B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....